This is an old revision of this page, as edited by Balon Greyjoy (talk | contribs) at 02:50, 29 December 2018 (v2.0 - WP:WCW project (Reference list missing)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 02:50, 29 December 2018 by Balon Greyjoy (talk | contribs) (v2.0 - WP:WCW project (Reference list missing))(diff) โ Previous revision | Latest revision (diff) | Newer revision โ (diff) Pharmaceutical compoundClinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C5H15NO7P2 |
Molar mass | 263.12 g/mol gยทmol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Olpadronic acid (INN; salt form olpadronate) is a bisphosphonate. It is used as part of a cancer symptom treatment support in cases of high blood calcium levels (hypercalcemia) and the reduction of fractures/pain that are the result of when cancer spreads to the bone (metastasis).
References
- "Zoledronic Acid - Chemotherapy Drugs - Chemocare". chemocare.com. Retrieved 2018-12-23.
Drugs for treatment of bone diseases (M05) | |
---|---|
Bisphosphonates | |
Bone morphogenetic proteins | |
Other |
|
This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it. |